JAMS

HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights

Retrieved on: 
Mercoledì, Maggio 15, 2024
Patient, JAMS, Prejudice, Ovarian cancer, Patent, Element, University, FDA, Bank statement, Sale, Autoimmune disease, Pancreatic cancer, Court, Research, Notifiable disease, Inflammation, G&A, District court, Clinical trial, Skin, Court of Chancery, Complaint, Pharmaceutical industry

MIRAMAR, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its first quarter ended March 31, 2024.

Key Points: 
  • MIRAMAR, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its first quarter ended March 31, 2024.
  • Dr. Hing C. Wong, Founder and CEO of HCW Biologics, stated, “We reached an important clinical development milestone in the first quarter of 2024.
  • Revenues: Revenues for the first quarters ended March 31, 2023 and 2024 were $41,883 and $1.1 million, respectively.
  • The Company incurred significant legal expenses in connection with this matter in the period ended March 31, 2024, and expects to continue to incur material costs and expenses through the third quarter of 2024.

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights

Retrieved on: 
Lunedì, Aprile 1, 2024
Research, Court of Chancery, Notifiable disease, Ovarian cancer, JAMS, Prejudice, District court, Inflammation, Patient, Sale, News, G&A, University, Cancer, Trial of the century, Bank statement, Loss, Complaint, Pancreatic cancer, Patent, Probability, Court, Pharmaceutical industry

MIRAMAR, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its fourth quarter and fiscal year ended December 31, 2023.

Key Points: 
  • MIRAMAR, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its fourth quarter and fiscal year ended December 31, 2023.
  • Dr. Hing C. Wong, Founder and CEO of HCW Biologics, stated, “These are exciting times at HCW Biologics.
  • Revenues: Revenues for the fourth quarters ended December 31, 2022 and 2023 were $1.3 million and $1.3 million, respectively.
  • Net loss: Net loss for the fourth quarters ended December 31, 2022 and 2023 were $5.4 million and $10.7 million, respectively.

The AAA-ICDR Foundation and the JAMS Foundation Grant $750,000 to Support the Ray Corollary Initiative

Retrieved on: 
Lunedì, Marzo 18, 2024
Professional Services, DEI (Diversity, Equity and Inclusion), Philanthropy, Other Philanthropy, Fund Raising, Finance, Foundation, JAMS, Pacific Islander, Organization, AAPI, Mandarin Oriental Hotel Group, Research, Woman, Data collection, Disability, Ray, AAA, RCI, Person, Nursing

The JAMS Foundation and the AAA-ICDR Foundation have granted $750,000 to support the Ray Corollary Initiative (RCI).

Key Points: 
  • The JAMS Foundation and the AAA-ICDR Foundation have granted $750,000 to support the Ray Corollary Initiative (RCI).
  • This is the mission of RCI, which is supported financially and in practice by JAMS and the AAA.
  • "The JAMS Foundation is proud to partner with the AAA-ICDR Foundation to support the Ray Corollary Initiative.
  • More information about the Ray Corollary Initiative can be found here.

People’s First Choice, LLC (“Blüm Santa Ana”) Granted Temporary Restraining Order Against New Patriot Holdings, Inc.

Retrieved on: 
Venerdì, Marzo 1, 2024
Janus, OTCQB, Hearing, BLMH, JAMS

Mr. Yadon is also a principal of People’s California, LLC, an entity involved in separate litigation with Unrivaled Brands, Inc., a wholly-owned subsidiary of Blüm.

Key Points: 
  • Mr. Yadon is also a principal of People’s California, LLC, an entity involved in separate litigation with Unrivaled Brands, Inc., a wholly-owned subsidiary of Blüm.
  • The matter involved parking spaces used by Blüm Santa Ana.
  • Blüm Santa Ana’s request for a Temporary Restraining Order argued that if New Patriot were allowed to terminate a parking agreement between the parties that Blüm Santa Ana’s business would be irreparably harmed and that Blüm Santa Ana was likely to prevail on its claim that New Patriot had breached the agreement by attempting to terminate Blüm Santa Ana’s right to access the parking.
  • The court found in Blüm Santa Ana’s favor that pending a hearing on a request for preliminary injunctive relief through JAMS, New Patriot, its officers, agents, servants, employees, and attorneys were directed to permit Blüm Santa Ana’s exclusive use and access to parking spaces.

Curaleaf Celebrates New Phoenix Airport Dispensary

Retrieved on: 
Martedì, Febbraio 20, 2024
JAMS, TSX, Phoenix Airport, Sky Harbor Airport, Coffee, Region, Curaleaf, Patient

NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it has relocated its Curaleaf Phoenix Airport dispensary to 4415 East Monroe Street, a newly updated and refreshed retail space. Curaleaf Phoenix Airport is the closest dispensary from highly trafficked 44th St., a major roadway to the Sky Harbor Airport.

Key Points: 
  • NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it has relocated its Curaleaf Phoenix Airport dispensary to 4415 East Monroe Street, a newly updated and refreshed retail space.
  • Curaleaf Phoenix Airport is the closest dispensary from highly trafficked 44th St., a major roadway to the Sky Harbor Airport.
  • The new location is situated in an optimal area of Phoenix, allowing for convenient access to new customers and to better serve existing customers.
  • Curaleaf Phoenix Airport is on the centrifuge loop of the airport, offering improved parking and proximity for visitors to the city.

Curaleaf Celebrates Launch of Adult Use Sales at Hudson Valley, NY Dispensary

Retrieved on: 
Mercoledì, Gennaio 24, 2024
Patient, I-84, Curaleaf, Social justice, War, Sale, TSX, Medicine, Workforce, JAMS, Cannabis, Nursing

NEW YORK, Jan. 24, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today celebrated the commencement of adult use sales at its Hudson Valley, New York location both in-person and through delivery. Located at 8 North Plank Road, Newburgh, New York, Curaleaf Hudson Valley is the Company's first retail location to welcome adult use patrons in the state.

Key Points: 
  • Located at 8 North Plank Road, Newburgh, New York, Curaleaf Hudson Valley is the Company's first retail location to welcome adult use patrons in the state.
  • Curaleaf Hudson Valley has added 1,750 square feet to its facility to accommodate adult use consumers, including building a brand new sales floor area, product vault, additional parking, and additional space at the point of sales system.
  • "We are thrilled to commence adult use sales at our Hudson Valley retail location," said Matt Darin, CEO Curaleaf.
  • Curaleaf Hudson Valley will celebrate the launch of adult use sales at a Grand Opening event on February 9, 2024 at 12 PM ET.

HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights

Retrieved on: 
Martedì, Novembre 14, 2023
Letter of recommendation, Principal, Sale, Prejudice, Gynecologic Oncology (journal), University, IND, Bank statement, Gynaecology, JAMS, Loan agreement, Clinical trial, Patient, Insurance, Research, Division, Immunotherapy, G&A, TGF, District court, Ovarian cancer, Human, SITC, R, Loss, Court, Society, Professor, Notifiable disease, Inflammation, DL2, Pharmaceutical industry, Medical imaging, Vaccine, Cryptocurrency, Cancer, Liver, Obstetrics

MIRAMAR, Fla., Nov. 14, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its third quarter ended September 30, 2023.

Key Points: 
  • MIRAMAR, Fla., Nov. 14, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its third quarter ended September 30, 2023.
  • We are pleased to see the consistency of results in humans with those that we saw in our preclinical animal studies.
  • Third Quarter 2023 Financial Results:
    Revenues: Revenues for the quarter ended September 30, 2022 and 2023 were $1.8 million and $853,102, respectively.
  • Revenues for the nine months ended September 30, 2022 and 2023 were $5.4 million and $1.5 million, respectively.

Santiago "Sam" Fernandez, Esq., Joins JAMS in Century City

Retrieved on: 
Lunedì, Dicembre 4, 2023
Legal, Professional Services, Baseball, Sports, The National Law Journal, Negotiation, Employment, AMEC, Hastings College, Intellectual property, University, Los Angeles Dodgers, ADR, Sport, Corporate lawyer, Coif, Order of the Coif, Property management, Law, JAMS

JAMS, the largest private provider of alternative dispute resolution (ADR) services worldwide, is pleased to announce the addition of Santiago "Sam" Fernandez, Esq.

Key Points: 
  • JAMS, the largest private provider of alternative dispute resolution (ADR) services worldwide, is pleased to announce the addition of Santiago "Sam" Fernandez, Esq.
  • Mr. Fernandez joins JAMS after over 38 years overseeing all legal affairs for Major League Baseball’s Los Angeles Dodgers.
  • In his role with the Dodgers, Mr. Fernandez was responsible for supervising disputed or litigated matters relating to all facets of the company’s business.
  • Based in the Century City Resolution Center , Mr. Fernandez will serve as a mediator, handling business/commercial, entertainment and sports, employment, intellectual property and personal injury/torts cases.

Baron & Budd Obtains Awards Over $52 Million on Behalf of Public Entities for Camp Fire

Retrieved on: 
Mercoledì, Novembre 22, 2023
Public Policy, Government, Legal, Professional Services, State, Local, Camp Fire (2018), Wildfire, Organization, City, Town, LLP, JAMS, Baron & Budd, P.C., The Salvation Army, RET, A Town Called Paradise, Campfire, PC, Trust, Red, FEMA, Water, Thermalito, California, Paradise

The City of Chico operated as the response and recovery hub for the Town of Paradise which was almost entirely destroyed by the fire.

Key Points: 
  • The City of Chico operated as the response and recovery hub for the Town of Paradise which was almost entirely destroyed by the fire.
  • The funds will compensate the City for damaged infrastructure, largely roadways damaged by tens of thousands of first responder, FEMA, utility, and construction trucks.
  • The Trust has also awarded over $9 million to the Thermalito Water & Sewer District for damages to its infrastructure, including sedimentation which affected its water systems.
  • The Camp Fire was the most destructive and deadliest wildfire in the state’s history burning through more than 153,000 acres and killing 85 people.

JAMS Launches New JAMS Pathways Website, Providing Tools and Easily Accessible Services for Organizations of All Types to Turn the Corner on Conflict

Retrieved on: 
Giovedì, Novembre 16, 2023
Legal, Technology, Other Communications, Human Resources, Consulting, Other Technology, Communications, Professional Services, Small Business, Other Professional Services, Higher education, Organization, Faculty, Patient, Professional, Region, Critical Access Hospital, Pacific Northwest, University, Communication, Government, Hospital, ADR, Physician, Nursing, Management, Risk management, JAMS

Early conflict resolution is an effective mechanism for avoiding litigation, and can in turn help organizations meet their end goals of increasing productivity and reducing legal costs.

Key Points: 
  • Early conflict resolution is an effective mechanism for avoiding litigation, and can in turn help organizations meet their end goals of increasing productivity and reducing legal costs.
  • Established in March 2022, JAMS Pathways fills the need for skilled organizational conflict intervention and prevention.
  • It has worked with entities from nonprofits to universities and hospitals to corporations, fast-growing startups and government agencies.
  • The Workplace Conflict Resolution Program is a customizable program that utilizes JAMS Pathways four-step P.A.T.H.